Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123992 · ClinicalTrials.gov registry record · Phase 4
Study of the Elevate Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse
A Phase 4 study, sponsored by ASTORA Women's Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 99
- Enrollment target
NCT02123992 is a Phase 4 study that was terminated before completion, run by ASTORA Women's Health. The registered enrollment target is 99 participants.
The verdict
NCT02123992, a Phase 4 study, was terminated before completion, sponsored by ASTORA Women's Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 99 participants
- Enrollment target
Study Summary
The aim of this study is to further evaluate the safety and efficacy of the Elevate® Apical and Posterior Prolapse Repair System for repair of apical/posterior pelvic organ prolapse in a controlled, post-market cohort study.
Interventions
- DEVICE Elevate Apical and Posterior
- PROCEDURE Native Tissue Repair for pelvic organ prolapse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02123992
The ClinicalTrials.gov registry entry for NCT02123992 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ASTORA Women's Health, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Elevate Apical and Posterior is the first listed.
NCT02123992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02123992 about?
NCT02123992 is a clinical study titled "Study of the Elevate Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse". The aim of this study is to further evaluate the safety and efficacy of the Elevate® Apical and Posterior Prolapse Repair System for repair of apical/posterior pelvic organ prolapse in a controlled, post-market cohort study.
What is the current status of trial NCT02123992?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 99 participants. The study started on 2014-04. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02123992?
The interventions under investigation include: Elevate Apical and Posterior (DEVICE), Native Tissue Repair for pelvic organ prolapse (PROCEDURE).
Who is sponsoring clinical trial NCT02123992?
This trial is sponsored by ASTORA Women's Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.